📰 Tilde Sciences News
Tilde Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tilde Sciences. Real-time updates on events, politics, business and more.
December 15, 2023
Check out this week’s medical marketing news, people on the move and industry chatter.
December 12, 2023
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, announces that Tilde Sciences, specializing in the development and commercialization of specialty pharmaceuticals, has chosen AscellaHealth’s Specialty Pharmacy, Optime Care as its exclusive distribution,...
December 7, 2023
/PRNewswire/ -- Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera...
August 3, 2023
As part of Vyera Pharmaceuticals’ bankruptcy, it will sell off Daraprim and hypertension drug Vecamyl to Tilde Sciences for $650,000.